Sep 29

PQA 06 - Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement

3251 - Dosimetric Outcomes of Cytoreductive Stereotactic Body Radiotherapy (SBRT) for Metastatic Renal Cell Carcinoma (mRCC): Data from the CYTOSHRINK Trial

02:15pm - 03:30pm ET

Poster Hall - Exhibit Hall A

Presenter(s)

Laura Collie, MD - Juravinski Cancer Center, Hamilton, ON